Publication Author: Basu_Anirban
-
Associations of Common Depression Treatment Metrics With Patient-centered Outcomes.
Carlo AD, Basu A, Unützer J. Associations of Common Depression Treatment Metrics With Patient-centered Outcomes. Med Care. 2021 Jul 1;59(7):579-587. doi: 10.1097/MLR.0000000000001540.
rakerr2
-
Catalog of Age- and Medical Condition-Specific Healthcare Costs in the United States to Inform Future Costs Calculations in Cost-Effectiveness Analysis.
Jiao B, Basu A. Catalog of Age- and Medical Condition-Specific Healthcare Costs in the United States to Inform Future Costs Calculations in Cost-Effectiveness Analysis. Value Health. 2021 Jul;24(7):957-965. doi: 10.1016/j.jval.2021.03.006. Epub 2021 Apr 2
rakerr2
-
Association of Branded Prescription Drug Rebate Size and Patient Out-of-Pocket Costs in a Nationally Representative Sample, 2007-2018.
Yeung K, Dusetzina SB, Basu A. Association of Branded Prescription Drug Rebate Size and Patient Out-of-Pocket Costs in a Nationally Representative Sample, 2007-2018. JAMA Netw Open. 2021 Jun 1;4(6):e2113393. doi: 10.1001/jamanetworkopen.2021.13393.
rakerr2
-
Clinical and utilization outcomes associated with tumor mutational burden in a real-world pan-tumor population.
Gautam S, Kachroo S, DeClue RW, Fisher MD, Basu A. Clinical and utilization outcomes associated with tumor mutational burden in a real-world pan-tumor population. J Comp Eff Res. 2021 Jul;10(10):857-868. doi: 10.2217/cer-2020-0288. Epub 2021 May 28.
rakerr2
-
Real-world patterns on tumor mutation burden testing in a pan-tumor population.
Gautam S, Kachroo S, DeClue RW, Fisher MD, Basu A. Real-world patterns on tumor mutation burden testing in a pan-tumor population. Future Oncol. 2021 Jan 29. doi: 10.2217/fon-2020-1005. [Epub ahead of print]
rakerr2
-
Do pharmaceutical prices rise anticipating branded competition?
Ellyson AM, Basu A. Do pharmaceutical prices rise anticipating branded competition? Health Econ. 2021 May;30(5):1070-1081. doi: 10.1002/hec.4248. Epub 2021 Mar 8.
rakerr2
-
Meta-analyzing count events over varying durations using the piecewise Poisson model: The case for poststroke seizures.
Wang WJ, Devine B, Bansal A, White HS, Basu A. Meta-analyzing count events over varying durations using the piecewise Poisson model: The case for poststroke seizures. Res Synth Methods. 2020 Nov 1. doi: 10.1002/jrsm.1465. [Epub ahead of print]
rakerr2
-
Quality-Adjusted Life-Year Losses Averted With Every COVID-19 Infection Prevented in the United States.
Basu A, Gandhay VJ. Quality-Adjusted Life-Year Losses Averted With Every COVID-19 Infection Prevented in the United States. Value Health. 2021 May;24(5):632-640. doi: 10.1016/j.jval.2020.11.013. Epub 2021 Mar 8.
rakerr2
-
Exploring Medication Adherence with P2Y(12) Inhibitors Using Conditional and Unconditional Quantile Regression Approaches.
Suh K, Basu A, Carlson JJ, Branch KR. Exploring Medication Adherence with P2Y(12) Inhibitors Using Conditional and Unconditional Quantile Regression Approaches. Am J Cardiovasc Drugs. 2020 Mar 30. doi: 10.1007/s40256-020-00405-1. [Epub ahead of print]
rakerr2
-
Online tools to synthesize real-world evidence of comparative effectiveness research to enhance formulary decision making.
Chen S, Graff J, Yun S, Beal B, Ta JT, Bansal A, Carlson JJ, Veenstra DL, Basu A, Devine B. Online tools to synthesize real-world evidence of comparative effectiveness research to enhance formulary decision making. J Manag Care Spec Pharm. 2021 Jan;27(1):
rakerr2